133 Long-term safety and efficacy of elexacaftor-tezacaftor-ivacaftor in children aged 6 and older with cystic fibrosis and at least one F508del allele: 144-week results of an open-label extension study
Journal of Cystic Fibrosis（2023）
关键词
cystic fibrosis,long-term,elexacaftor-tezacaftor-ivacaftor,open-label
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要